MedTrace Logo

Comparison of New Contact Lens With Current Marketed Lens

NCT03360110 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2020-09-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to validate the clinical performance of a new contact lens design.

Conditions

  • Myopia

Interventions

DEVICE

Phoebe test lens

Daily disposable contact lens

DEVICE

stenfilcon A lens (control)

Daily disposable contact lens

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Peter S Kolbaum, O.D., Ph.D., FAAO, FBCLA · Clinical Optics Research Lab (CORL), Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-06
Primary Completion
2017-12-15
Completion
2017-12-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03360110 on ClinicalTrials.gov